Skip to content

Clinical trials

Head and Neck Neoplasms trials in the United Kingdom with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Head and Neck Neoplasms Phase: Not applicable Country / region: United Kingdom Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20061
20071
20081
20162
20172
20211
20222
20243

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Unknown status4
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Guy's and St Thomas' NHS Foundation Trust2
Cardiff and Vale University Health Board1
East and North Hertfordshire NHS Trust1
European Organisation for Research and Treatment of Cancer - EORTC1
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano1
Liverpool University Hospitals NHS Foundation Trust1
Queen Mary University of London1
Sheffield Teaching Hospitals NHS Foundation Trust1
Terrence Jones1
The Facial Surgery Research Foundation1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Head and Neck Neoplasms14
Breast Neoplasms3
Squamous Cell Carcinoma of Head and Neck3
Tongue Neoplasms3
Colonic Neoplasms2
Esophageal Neoplasms2
Neoplasms2
Pancreatic Neoplasms2
Salivary Gland Neoplasms2
Breast Neoplasms, Male1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.